Add to ORKGBackground Successful highly active antiretroviral therapy (HAART) has changed the outcome of AIDS patients worldwide because the complete suppression of viremia improves health and pro-longs life expectancy of HIV-1+ patients. However, little attention has been given to the immunological profile of patients under distinct HAART regimens. This work aimed to inves-tigate the differences in the immunological pattern of HIV-1+ patients under the first- or sec-ond-line HAART in Brazil
Background: We investigated differences in immune restoration and onset of new AIDS-defining events ...
The course of human immunodeficiency virus (HIV) disease is characterized by a progressive decline i...
Efforts to characterize HIV-1 polymorphism and anti-HIV immune response are being made in areas wher...
<div><p>Background</p><p>Successful highly active antiretroviral therapy (HAART) has changed the out...
Highly active antiretroviral treatment (HAART) of human immunodeficiency type 1 (HIV-1) infection is...
The aim of this paper was to evaluate the immune reconstitution of HIV-1 patients subjected to highl...
OBJECTIVE: To evaluate the immunological and virological responses to highly active antiretroviral t...
Background: Suppression of human immunodeficiency virus (HIV) replication can be obtained in chronic...
Highly active antiretroviral treatment(HAART) of human immunodeficiency type 1 (HIV-1) infection is ...
Background Immunological and virological status of HIV-infected individuals entering the Brazilian p...
Background: The prognostic value of discordant immunologic (CD4 cell increase) and virologic (plasma...
OBJECTIVE: When to start highly active antiretroviral therapy (HAART) in asymptomatic chronically HI...
In order to investigate the IgG HIV-1 antibodies rectivity to structural components of the virus, 85...
International audienceBACKGROUND: HIV-2 is known to be less pathogenic than HIV-1, although the unde...
Objectives: To evaluate prior antiretroviral therapy experience and host characteristics as determin...
Background: We investigated differences in immune restoration and onset of new AIDS-defining events ...
The course of human immunodeficiency virus (HIV) disease is characterized by a progressive decline i...
Efforts to characterize HIV-1 polymorphism and anti-HIV immune response are being made in areas wher...
<div><p>Background</p><p>Successful highly active antiretroviral therapy (HAART) has changed the out...
Highly active antiretroviral treatment (HAART) of human immunodeficiency type 1 (HIV-1) infection is...
The aim of this paper was to evaluate the immune reconstitution of HIV-1 patients subjected to highl...
OBJECTIVE: To evaluate the immunological and virological responses to highly active antiretroviral t...
Background: Suppression of human immunodeficiency virus (HIV) replication can be obtained in chronic...
Highly active antiretroviral treatment(HAART) of human immunodeficiency type 1 (HIV-1) infection is ...
Background Immunological and virological status of HIV-infected individuals entering the Brazilian p...
Background: The prognostic value of discordant immunologic (CD4 cell increase) and virologic (plasma...
OBJECTIVE: When to start highly active antiretroviral therapy (HAART) in asymptomatic chronically HI...
In order to investigate the IgG HIV-1 antibodies rectivity to structural components of the virus, 85...
International audienceBACKGROUND: HIV-2 is known to be less pathogenic than HIV-1, although the unde...
Objectives: To evaluate prior antiretroviral therapy experience and host characteristics as determin...
Background: We investigated differences in immune restoration and onset of new AIDS-defining events ...
The course of human immunodeficiency virus (HIV) disease is characterized by a progressive decline i...
Efforts to characterize HIV-1 polymorphism and anti-HIV immune response are being made in areas wher...